V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330001863 | 330001063 | 1.72 | null | Curative (C) | 2018-08-12 | 2018-08-16 | Trial Unspecified | 1 | N | 330007327 | TRIAL |
| 330001864 | 330001063 | 1.6 | 5.5 | Curative (C) | null | 2017-03-27 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330007327 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001867 | 330001065 | null | 67.4 | Curative (C) | 2014-08-20 | 2014-09-08 | CYCLOPHOSPHAMIDE + RITUXIMAB + prednisolone | Y | N | 330007346 | NOT MATCHED |
| 330001868 | 330001065 | 1.6 | null | null | 2016-01-16 | 2016-01-24 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330007346 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001869 | 330001066 | null | 72.1 | Curative (C) | 2015-01-12 | 2015-02-07 | Cisplatin | 02 | null | 330007351 | CISPLATIN |
| 330001870 | 330001066 | 1.81 | 65 | Curative (C) | 2015-01-08 | 2015-01-14 | Cisplatin | N | N | 330007351 | CISPLATIN |
| 330001871 | 330001067 | 1.52 | 77.6 | null | null | 2014-09-28 | Cisplatin | N | Y | 330007356 | CISPLATIN |
| 330001872 | 330001068 | 1.59 | 98 | Neo-adjuvant (N) | null | 2015-08-01 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 330007357 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001873 | 330001069 | null | 80.9 | Curative (C) | 2015-03-05 | 2015-03-16 | NB Low/Interm risk guidelines Carbo/Etop | N | N | 330007358 | NOT MATCHED |
| 330001874 | 330001069 | null | null | Neo-adjuvant (N) | 2014-04-16 | 2014-05-15 | Cisplatin 7 day | 02 | N | 330007358 | CISPLATIN |
| 330001875 | 330001070 | 1.65 | 54.3 | Curative (C) | 2017-08-13 | 2017-08-20 | Cisplatin | N | Y | 330007362 | CISPLATIN |
| 330001876 | 330006578 | 1.75 | 69.4 | Neo-adjuvant (N) | 2014-05-12 | 2014-05-28 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 330007365 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001877 | 330006578 | 1.72 | 67.7 | Neo-adjuvant (N) | null | 2016-10-25 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330007365 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001878 | 330001071 | 1.75 | null | Adjuvant (A) | 2015-10-23 | 2015-11-13 | Cisplatin | N | N | 330007377 | CISPLATIN |
| 330001879 | 330001072 | 1.8 | 76.4 | Neo-adjuvant (N) | null | 2017-11-26 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330007378 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001880 | 330001073 | null | 64.3 | null | 2016-01-14 | 2016-01-24 | STS Rhabdomyosarcoma RMS 2005 IVAVV | N | N | 330007381 | NOT MATCHED |
| 330001881 | 330001074 | null | 96.3 | Curative (C) | 2016-10-30 | 2016-11-11 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330007382 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001882 | 330001075 | 1.84 | 47.8 | null | 2013-05-27 | 2013-06-27 | Cisplatin 7 day | N | Y | 330007384 | CISPLATIN |
| 330001883 | 330001075 | 1.7 | null | Neo-adjuvant (N) | 2016-06-08 | 2016-06-14 | Cisplatin + Docetaxel +Fluorouracil | N | null | 330007384 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001884 | 330001076 | 1.62 | 13.8 | Adjuvant (A) | 2014-06-04 | 2014-06-11 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330007389 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001885 | 330001076 | 1.7 | 20.4 | null | null | 2015-03-23 | Cisplatin + Docetaxel +Fluorouracil | null | null | 330007389 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001886 | 330001076 | null | null | Curative (C) | 2016-03-17 | 2016-03-17 | EW EuroEwing 2012 Arm B VDC | N | N | 330007389 | TRIAL |
| 330001887 | 330001076 | null | 15.1 | Curative (C) | 2018-01-10 | 2018-01-16 | NB HRNBL-1 COJEC Ind COURSE A | N | N | 330007389 | NOT MATCHED |
| 330001888 | 330001076 | 1.6 | 52 | Curative (C) | 2016-03-27 | 2016-03-27 | EW EuroEwing 2012 Arm A VAC | null | N | 330007389 | NOT MATCHED |
| 330001889 | 330001076 | null | 15 | Neo-adjuvant (N) | 2014-04-07 | 2014-04-07 | Trial Unspecified | 1 | Y | 330007389 | TRIAL |
| 330001890 | 330001077 | 1.68 | null | Curative (C) | 2013-05-04 | 2013-05-18 | Cisplatin | N | Y | 330007417 | CISPLATIN |
| 330001891 | 330001078 | 1.78 | 89.6 | null | 2017-07-12 | 2017-07-26 | Cisplatin | N | Y | 330007421 | CISPLATIN |
| 330001894 | 330001079 | 1.7 | null | Curative (C) | null | 2014-03-31 | Cisplatin | N | N | 330007430 | CISPLATIN |
| 330001895 | 330006582 | 1.81 | 60 | Neo-adjuvant (N) | 2016-10-15 | 2016-11-24 | Cisplatin + Docetaxel +Fluorouracil | null | null | 330007432 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001896 | 330001080 | 1.55 | 77.6 | Curative (C) | 2015-06-02 | 2015-06-04 | NB HRNBL-1 COJEC Ind COURSE A | Y | null | 330007433 | NOT MATCHED |
| 330001897 | 330001080 | 1.7 | null | Neo-adjuvant (N) | 2014-10-19 | 2014-10-25 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | N | 330007433 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001898 | 330001081 | null | 58 | Palliative (P) | 2015-11-04 | 2015-11-04 | NB Low/Interm risk guidelines Carbo/Etop | 02 | N | 330007437 | NOT MATCHED |
| 330001899 | 330001081 | null | 20.3 | Curative (C) | 2015-10-21 | 2015-10-22 | STS Rhabdomyosarcoma RMS 2005 IVAVV | N | Y | 330007437 | NOT MATCHED |
| 330001900 | 330001082 | null | 13 | Not known (9) | 2013-06-07 | 2013-06-08 | Trial Unspecified | 2 | N | 330007444 | TRIAL |
| 330001902 | 330001084 | 1.6 | 49.2 | Curative (C) | 2016-08-13 | 2016-08-18 | Trial Unspecified | Y | N | 330007452 | TRIAL |
| 330001903 | 330001084 | 1.8 | 51.7 | Curative (C) | 2015-03-04 | 2015-03-19 | Cisplatin 7 day | 02 | N | 330007452 | CISPLATIN |
| 330001904 | 330001085 | 1.8 | 68 | Adjuvant (A) | 2018-01-09 | 2018-01-29 | Cisplatin 7 day | N | Y | 330007455 | CISPLATIN |
| 330001905 | 330001085 | 1.72 | null | Neo-adjuvant (N) | 2017-09-09 | 2017-09-18 | Cisplatin + Docetaxel +Fluorouracil | null | null | 330007455 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001911 | 330001087 | 1.74 | 56 | Curative (C) | null | 2016-11-16 | Cisplatin | 02 | N | 330007475 | CISPLATIN |
| 330001912 | 330001087 | 1.79 | null | Neo-adjuvant (N) | 2014-11-12 | 2014-11-26 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 330007475 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001913 | 330001088 | null | 62.9 | Curative (C) | 2013-12-08 | 2014-01-05 | Cisplatin 7 day | 02 | Y | 330007478 | CISPLATIN |
| 330001914 | 330001089 | 1.6 | 69.2 | Curative (C) | 2015-02-11 | 2015-03-14 | Trial Unspecified | Y | Y | 330007479 | TRIAL |
| 330001915 | 330001090 | 1.67 | 98.8 | Neo-adjuvant (N) | 2013-03-30 | 2013-04-06 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330007480 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001916 | 330001090 | 1.58 | 63 | Curative (C) | 2014-08-30 | 2014-09-01 | EW EuroEwing 2012 Arm B VDC | N | N | 330007480 | TRIAL |
| 330001917 | 330001090 | 1.4 | 0 | Curative (C) | 2012-11-21 | 2013-07-06 | NB HRNBL | 02 | N | 330007480 | NOT MATCHED |
| 330001918 | 330001090 | null | 99.2 | Curative (C) | 2017-09-13 | 2017-09-13 | NB HRNBL-1 COJEC Ind COURSE A | N | N | 330007480 | NOT MATCHED |
| 330001919 | 330001090 | null | 63.6 | Curative (C) | 2013-08-25 | 2013-08-25 | NB HRNBL-1 COJEC Ind COURSE A | N | N | 330007480 | NOT MATCHED |
| 330001920 | 330001091 | null | 57.1 | Neo-adjuvant (N) | 2015-06-17 | 2015-06-25 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330007492 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001921 | 330001091 | 1.55 | 6.8 | Curative (C) | 2015-08-07 | 2015-08-07 | Cisplatin | N | Y | 330007492 | CISPLATIN |
| 330001922 | 330001092 | 1.67 | 100.8 | Curative (C) | 2018-01-15 | 2018-02-07 | Cisplatin | 02 | N | 330007502 | CISPLATIN |